헤르페스 바이러스를 이용한 두경부암의 유전자 치료 = Herpes Viral Gene Therapy for the Treatment of Head and NeckSquamous Cell Carcinoma

참고문헌 (Reference)

1 "The carboxylterminus of the murine MyD116 gene substitutes for the correspondingdomain of theγ134 5 gene of herpes simplex virus to preclude thepremature shutoff of total protein synthesis in infected human cells" 70 : 84-90, 1996

2 "The ADA human gene therapyclinical protocol" 1 : 331-62, 1990

3 "Selectiveinfection and cytolysis of human head and neck squamous cell carcinomawith sparing of normal mucosa by a cytotoxic herpes simplexvirus type 1" 10 : 1599-1606, 1999

4 "Rapid production of interleukine-2-secreting tumor cells by herpessimplex virus-mediated gene transfer:Implications for autologousvaccine production" 7 : 2217-2224, 1996

5 "Rapid and efficient gene transfer in human hepatocytes byherpes viral vectors" 22 : 723-729, 1995

6 "Oncolytic viral therapy for human colorectal cancerand liver metastases using a multi-mutated herped simplex virus type-1" 13 : 1325-1334, 1999

7 "Nationalcancer data base report on cancer of the head and neck" 124 : 951-962, 1998

8 "Mapping of herpes simplexvirus-1 neurovirulence to gamma 34 a gene nonessential for growthin culture" 1262-6, science1990

9 "Interleukin-12 gene therapy prevents establishment ofSCCVII squamous cell carcinomas, Inhibits tumor growth, and elicitslong-term antitumor immunity in syngeneic C3H mice" 108 : 261-268, 1998

10 "In vivo molecular therapy withp53 adenovirus for microscopic residual head and neck suqamouscarcinoma" 55 : 1-6, 1995

11 "Immunity to methylcholanthrene induced sarcomas" 18 : 767-78, 1957

12 "Head andNeck Cancer" 328 : 184-94, 1993

13 "Genotoxic stress confers preferentialand coordinate messenger RNA stability on the five gadd genes" 54 : 5656-62, 1994

14 "Expression of ribonucleotide reductase afterionizing radiation in human cervical carcinoma cells" 58 : 2245-2252, 1998

15 "Ex vivo gene therapy using cytokine-transducedtumor vaccines: Molecular and clinical pharmacology" Sem Oncol 661-676, 1998

16 "Efficient gene transfer to humn squamous cell carcinoma by theherpes simplex virus type1 amplicon vector" 176 : 404-408, 1998

17 "Effectivetreatment of head and neck squamous cell carcinoma by an oncolyticherpes simplex virus" 193 : 12-21, 2001

18 "Cytokine gene transfer enhances herpes oncolytic therapy inmurine squamous cell carcinoma" 12 : 253-265, 2001

19 "Combinationgene therapy for oral cancer in a murine model" 56 : 1737-1741, 1996

20 "Combination of mutated herpes simplex virus type 1 with radiation for the treatment of squamous cell carcinoma of thehead and neck" 41 : 313-322, 2005

21 "Combination gene therapy using multiple immunomodulatory genestransferred by a defective infectious single-cycle herpes virus in squamouscell cancer" 7 : 1279-1285, 2000

22 "Clinical promise of tumor immunology" 349 : 19-22, 1997

23 "Attenuatedmulti-mutated herpes simplex virus-1 for the treatment of malignantgliomas" 1 : 938-943, 1995

24 "An efficient deletionmutation packaging system for defective herpes simplex virus vectors:Potential applications to human gene therapy and neuronal physiology" 87 : 8950-4, 1990